Key Statistics About Thyroid Cancer

Key points
- About 44,670 new cases of thyroid cancer will occur (33,930 in women, and 10,740 in men) Thyroid cancer will cause about 1,690 deaths (960 women and 730 men).
- Early thyroid cancer often does not have symptoms.
- From 2004-2008, the median age at death for cancer of the thyroid was 74 years of age.
- From 2004-2008, the median age at diagnosis for cancer of the thyroid was 49 years of age3.
The American Cancer Society's most recent estimates for thyroid cancer in the United States are for 2010:
About 44,670 new cases of thyroid cancer will occur (33,930 in women, and 10,740 in men)
Thyroid cancer will cause about 1,690 deaths (960 women and 730 men).
In general, this is one of the least deadly cancers. The 5-year survival rate (the percentage of people living at least 5 years after being diagnosed) for all cases is about 97 percent.
Thyroid cancer is different from many other adult cancers in that it is commonly diagnosed in younger people. Nearly 2 of 3 cases are found in people between the ages of 20 and 55.
The chance of being diagnosed with thyroid cancer has risen in recent years and is now more than twice what it was in 1990. Some of this increase may be the result of the increased use of thyroid ultrasound, which detects small thyroid nodules that might not otherwise have been found. Still, at least part of the increase is from finding more larger tumors, as well. The death rate from thyroid cancer has been fairly stable for many years, and remains extremely low compared with most cancers.
Thyroid Cancer Survival by Type and Stage
Survival rates are often used by doctors as a standard way of discussing a person's prognosis (outlook). Some patients with cancer may want to know the survival statistics for people in similar situations, while others may not find the numbers helpful, or may even not want to know them. Whether or not you want to read about the survival statistics below for thyroid cancer is up to you.
The 5-year survival rate refers to the percentage of patients who live at least 5 years after their cancer is diagnosed. Of course, many people live much longer than 5 years (and many are cured).
Five-year relative survival rates assume that some people will die of other causes and compare the observed survival with that expected for people without the cancer. This is a more accurate way to describe the prognosis for patients with a particular type and stage of cancer.
In order to get 5-year survival rates, doctors have to look at people who were treated at least 5 years ago. Improvements in treatment since then may result in a more favorable outlook for people now being diagnosed with thyroid cancer.
Symptoms
Early thyroid cancer often does not have symptoms. But as the cancer grows, symptoms may include:
A lump in the front of the neck
Hoarseness or voice changes
Swollen lymph nodes in the neck
Trouble swallowing or breathing
Pain in the throat or neck that does not go away
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsRemoval of lymph nodes during surgery for thyroid cancer may be beneficial
Papillary thyroid cancer accounts for the majority of all thyroid malignancies, which primarily impact women. A new study indicates that routinely removing lymph nodes in the neck in these cancer patients may help…
21 December 2011
NewsBRAF addiction of thyroid cancers makes them therapeutically vulnerable
Papillary carcinoma is the most common form of thyroid cancer. Approximately one quarter of these carcinomas have mutations in the BRAF gene. The prevalence of such mutations is even greater in high-grade carcinomas,…
22 November 2011
NewsThyroid Cancer Treatment Varies by Hospital
Where thyroid cancer patients go for care plays a large role in whether they receive radioactive iodine treatment, a new study from the University of Michigan Comprehensive Cancer Center finds. While the size and…






